These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30178686)

  • 1. Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting.
    Gao J; Liu Y; Li YM
    J Int Med Res; 2018 Dec; 46(12):4907-4919. PubMed ID: 30178686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.
    Liu Y; Wang HB; Li X; Xiao JY; Wang JX; Reilly KH; Sun B; Gao J
    BMC Cardiovasc Disord; 2018 Dec; 18(1):233. PubMed ID: 30541457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five-parameter score for predicting saphenous vein graft degenerative and/or occlusive disease in recurring ischemic symptoms after one year post coronary artery bypass grafting.
    Li XW; Cui Z; Xiao JY; Gao MD; Zhang M; Zhang WJ; Tian FS; Song Y; Liu YW; Yao ZH; Ma J; Liu Y; Gao J
    Perfusion; 2023 May; 38(4):843-852. PubMed ID: 35583035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting.
    Demircelik B; Cakmak M; Nazli Y; Gurel OM; Akkaya N; Cetin M; Cetin Z; Selcoki Y; Kurtul A; Eryonucu B
    Clin Invest Med; 2014 Oct; 37(5):E338-44. PubMed ID: 25282140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting].
    Li XW; Liu Y; Gao J; Gao MD; Xiao JY; Qu ZP; Wang YY; Feng LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):367-372. PubMed ID: 32450652
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.
    Gao J; Wang HB; Xiao JY; Ren M; Reilly KH; Li YM; Liu Y
    BMJ Open; 2018 Jul; 8(7):e021951. PubMed ID: 29991632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of virtual histological intravascular ultrasound in plaque composition assessment of saphenous vein graft diseases.
    Gao J; Wang YY; Liu Y
    Chin Med J (Engl); 2019 Apr; 132(8):957-962. PubMed ID: 30958438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between neutrophil-to-lymphocyte ratio and saphenous vein graft disease in patients with coronary bypass.
    Doğan M; Akyel A; Cimen T; Öksüz F; Celik IE; Aytürk M; Murat SN; Yeter E
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):25-9. PubMed ID: 23653146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plateletcrit. A platelet marker associated with saphenous vein graft disease.
    Akpinar I; Sayin MR; Gursoy YC; Karabag T; Kucuk E; Buyukuysal MC; Aydin M; Haznedaroglu IC
    Herz; 2014 Feb; 39(1):142-8. PubMed ID: 23575980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology and management of saphenous vein graft disease.
    Ghandakly EC; Tipton AE; Bakaeen FG
    Expert Rev Cardiovasc Ther; 2023; 21(8):565-572. PubMed ID: 37540160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saphenous vein graft disease: review of pathophysiology, prevention, and treatment.
    Kim FY; Marhefka G; Ruggiero NJ; Adams S; Whellan DJ
    Cardiol Rev; 2013; 21(2):101-9. PubMed ID: 22968180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Platelet to Lymphocyte Ratio and Saphenous Vein Graft Disease.
    Yayla Ç; Canpolat U; Akyel A; Yayla KG; Yilmaz S; Açikgöz SK; Özcan F; Turak O; Doğan M; Yeter E; Aydoğdu S
    Angiology; 2016 Feb; 67(2):133-8. PubMed ID: 25818104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHA2DS2-Vasc score and saphenous vein graft disease in patients with coronary artery bypass graft surgery.
    Yarlioglues M; Oksuz F; Yalcinkaya D; Duran M; Murat SN
    Coron Artery Dis; 2020 May; 31(3):243-247. PubMed ID: 31658138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass.
    Akboga MK; Yayla C; Balci KG; Ozeke O; Maden O; Kisacik H; Temizhan A; Aydogdu S
    Thorac Cardiovasc Surg; 2017 Jun; 65(4):315-321. PubMed ID: 27111497
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
    Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
    JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial.
    Kulik A; Voisine P; Mathieu P; Masters RG; Mesana TG; Le May MR; Ruel M
    Ann Thorac Surg; 2011 Oct; 92(4):1284-90; discussion 1290-1. PubMed ID: 21958773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The saphenous vein graft diseases].
    Yavuz T; Kutsal A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1, endothelin receptor antagonists, and vein graft occlusion in coronary artery bypass surgery: 20 years on and still no journey from bench to bedside.
    Dashwood MR; Loesch A
    Can J Physiol Pharmacol; 2020 Sep; 98(9):570-578. PubMed ID: 32343914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
    Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
    J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.